Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners

被引:109
作者
Li, CY [1 ]
Naren, AP [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis transmembrane conductance regulator; macromolecular complex; PDZ protein; interacting partner;
D O I
10.1016/j.pharmthera.2005.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) is the product of the gene mutated in patients with cystic fibrosis (CF). CFTR is a cAMP-regulated chloride channel localized primarily at the apical or luminal surfaces of epithelial cells lining the airway, gut, exocrine glands, etc., where it is responsible for transepithelial salt and water transport. CFTR chloride channel belongs to the superfamily of the ATP-binding cassette (ABC) transporters, which bind ATP and use the energy to drive the transport of a wide variety of substrates across extra- and intracellular membranes. A growing number of proteins have been reported to interact directly or indirectly with CFTR chloride channel, suggesting that CFTR might regulate the activities of other ion channels, receptors, or transporters, in addition to its role as a chloride conductor. The molecular assembly of CFTR with these interacting proteins is of great interest and importance because several human diseases are attributed to altered regulation of CFTR, among which cystic fibrosis is the most serious one. Most interactions primarily occur between the opposing terminal tails (N- or C-) of CFTR and its binding partners, either directly or mediated through various PDZ domain-containing proteins. These dynamic interactions impact the channel function as well as the localization and processing of CFTR protein within cells. This review focuses on the recent developments in defining the assembly of CFTR-containing complexes in the plasma membrane and its interacting proteins. (c) 2005 Elsevier Inc.. All rights reserved.
引用
收藏
页码:208 / 223
页数:16
相关论文
共 132 条
[41]   Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells [J].
Hallows, KR ;
Kobinger, GP ;
Wilson, JM ;
Witters, LA ;
Foskett, JK .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (05) :C1297-C1308
[42]   Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells [J].
Hallows, KR ;
McCane, JE ;
Kemp, BE ;
Witters, LA ;
Foskett, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :998-1004
[43]   Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase [J].
Hallows, KR ;
Raghuram, V ;
Kemp, BE ;
Witters, LA ;
Foskett, JK .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1711-1721
[44]   The AMP-activated protein kinase - Fuel gauge of the mammalian cell? [J].
Hardie, DG ;
Carling, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (02) :259-273
[45]  
Harris BZ, 2001, J CELL SCI, V114, P3219
[46]   C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins [J].
Hegedüs, T ;
Sessler, T ;
Scott, R ;
Thelin, W ;
Bakos, É ;
Váradi, A ;
Szabó, K ;
Homolya, L ;
Milgram, SL ;
Sarkadi, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (03) :454-461
[47]   CLONING AND EXPRESSION OF AN INWARDLY RECTIFYING ATP-REGULATED POTASSIUM CHANNEL [J].
HO, K ;
NICHOLS, CG ;
LEDERER, WJ ;
LYTTON, J ;
VASSILEV, PM ;
KANAZIRSKA, MV ;
HEBERT, SC .
NATURE, 1993, 362 (6415) :31-38
[48]   Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells [J].
Huang, PB ;
Lazarowski, ER ;
Tarran, R ;
Milgram, SL ;
Boucher, RC ;
Stutts, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :14120-14125
[49]   PDZ domains: Structural modules for protein complex assembly [J].
Hung, AY ;
Sheng, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :5699-5702
[50]  
Hyams J S, 2000, Pediatr Rev, V21, P291, DOI 10.1542/pir.21-9-291